FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label ...

The US Food and Drug Administration is urging all patients with smartphone-compatible diabetes devices to check their phone configurations to ensure all safety alerts are being received.

The FDA has issued a safety communication regarding the potential for missed alerts with diabetes devices due to software or hardware changes.

Certain smartphone features such as battery saver, “focus mode” or “do not disturb” may change how alerts are delivered. The Food and Drug Administration (FDA) has issued a safety ...

The US Food and Drug Administration (FDA) is cautioning patients and caregivers about the potential for not receiving blood glucose level alerts from diabetes-related smartphone devices due to ...

On Wednesday, Teladoc Health reported that its 2024 revenue dropped 1% to $2.57 billion. The company projected a revenue ...

and smartphone operating system updates that are not supported by the medical device application. The FDA's safety communication provides recommendations, such as the following, for users of these ...

The US FDA warns users of smartphone-linked diabetes devices like CGMs and insulin pumps of potential health risks due to missed critical alerts. Issues arise from software configuration ...

The FDA is working with diabetes-related medical device manufacturers to ensure that smartphone alert configurations of their devices are carefully evaluated prior to use by patients. The agency ...

Google's Loss of Pulse Detection feature has been given FDA clearance and is coming to US Pixel Watch 3 users soon.

The US Food and Drug Administration (FDA) is alerting patients of a safety concern regarding diabetes devices, such as continuous glucose monitors (CGMs), insulin pumps and automated insulin dosing ...